DI LORENZO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 475
NA - Nord America 384
AS - Asia 224
SA - Sud America 25
AF - Africa 17
OC - Oceania 1
Totale 1.126
Nazione #
US - Stati Uniti d'America 380
RU - Federazione Russa 290
SG - Singapore 101
IT - Italia 58
CN - Cina 53
NL - Olanda 42
HK - Hong Kong 40
FI - Finlandia 25
IE - Irlanda 23
BR - Brasile 22
VN - Vietnam 22
DE - Germania 19
CI - Costa d'Avorio 15
AT - Austria 3
FR - Francia 3
GB - Regno Unito 3
AR - Argentina 2
BE - Belgio 2
CA - Canada 2
IN - India 2
JP - Giappone 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BZ - Belize 1
CL - Cile 1
ES - Italia 1
JO - Giordania 1
LT - Lituania 1
MX - Messico 1
Totale 1.126
Città #
Chandler 59
Moscow 58
Singapore 57
Amsterdam 40
Ashburn 40
Hong Kong 40
Dong Ket 22
Naples 21
Princeton 20
Santa Clara 16
Beijing 15
Boston 15
Nanjing 15
Millbury 14
Napoli 12
Wilmington 8
Washington 7
Des Moines 6
Dallas 5
Dublin 5
Helsinki 5
Tianjin 5
Aversa 3
Changsha 3
Falkenstein 3
Nanchang 3
Shenyang 3
São Paulo 3
Courcelles 2
Frankfurt am Main 2
Hebei 2
Jacksonville 2
Munich 2
Norwalk 2
Ottawa 2
Rio de Janeiro 2
Seattle 2
Shanghai 2
Warsaw 2
Abidjan 1
Abreu e Lima 1
Amman 1
Arujá 1
Augusta 1
Belize City 1
Berazategui 1
Boardman 1
Brasília 1
Buffalo 1
Capinzal 1
Concordia 1
Contagem 1
Coruripe 1
Darmstadt 1
Dearborn 1
Falls Church 1
Indiana 1
Istanbul 1
Jaboatão dos Guararapes 1
Jequié 1
Jiaxing 1
Leawood 1
Limoeiro do Norte 1
Los Angeles 1
Mexico City 1
Mumbai 1
Nova Iguaçu 1
Nuremberg 1
Nürnberg 1
Orindiúva 1
Palermo 1
Pune 1
Raleigh 1
Redwood City 1
Ribeirão Preto 1
Rio Grande 1
San Francisco 1
Santiago 1
Santo André 1
Santos 1
Sciacca 1
Simões Filho 1
Sofia 1
Taizhou 1
Tokyo 1
Tula 1
Turin 1
Turku 1
Valenzano 1
Vienna 1
Vitória da Conquista 1
Totale 577
Nome #
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature 75
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 70
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 69
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 68
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 66
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 64
. 2009 Apr;20(4):. Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients. 62
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 62
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 60
Imatinib mesylate in thymic epithelial malignancies. 58
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 57
A djuvant treatment in patients at high risk of recurrence of thymoma: Efficacy and safety of a three-dimensional conformal radiation therapy regimen 57
The emerging role of obesity, diet and lipid metabolism in prostate cancer 56
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 55
Lack of cumulative toxicity associated with cabazitaxel use in prostate cancer 53
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 53
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation 48
An adjusted indirect comparison of everolimus andsorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 46
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). 43
Tumori urologici 36
Totale 1.158
Categoria #
all - tutte 5.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 0 12 0
2020/202136 0 0 0 0 6 2 0 0 1 0 4 23
2021/2022121 0 0 0 2 4 1 1 5 19 11 35 43
2022/2023175 21 6 9 2 24 19 0 14 30 40 7 3
2023/2024132 4 18 19 14 7 29 2 15 0 1 12 11
2024/2025559 20 25 0 12 25 15 66 42 30 53 271 0
Totale 1.158